Italia markets closed
FTSE MIB
35.398,82 -11,31 (-0,03%) Dow Jones
40.003,59 +134,21 (+0,34%) Nasdaq
16.685,97 -12,35 (-0,07%) Nikkei 225
38.787,38 -132,88 (-0,34%) Petrolio
80,00 +0,77 (+0,97%) Bitcoin EUR
61.578,18 +1.591,92 (+2,65%)
DaVita Inc (TRL.MU)
Munich - Munich Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
Alla chiusura: 08:06AM CEST
| Chiusura precedente | 127,25 |
| Aperto | 126,25 |
| Denaro | 128,55 x 0 |
| Lettera | 128,85 x 0 |
| Min-Max giorno | 126,25 - 126,25 |
| Intervallo di 52 settimane | 69,88 - 138,75 |
| Volume | |
| Media Volume | 5 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 01 ago 2024 - 05 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.